Skip to content

Author

Giovanni Mori

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Temocillin for the Treatment of Urinary Tract Infections: First Italian Data from a Multicentre Real-World Experience

Background: Temocillin is a narrow-spectrum β-lactam with activity against extended-spectrum β-lactamase (ESBL)- and AmpC-producing Enterobacterales and represents a potential carbapenem-sparing option, especially for urinary tract infections (UTIs). This multicentre study evaluated the real-world use, clinical outcome...

Nicola Benvenuto, Massimiliano Lanzafame, S. Venturini et al. · 0 citations
Review Open access Oct 2026

The unmet need for long-acting, narrow-spectrum antibiotics: a narrative review and call to action for antimicrobial stewardship

Abstract Long-acting lipoglycopeptides (laLGPs) are classified as Reserve agents under the WHO AWaRe framework, yet they are increasingly used as consolidation and suppressive therapy for Gram-positive bacteremia, endocarditis, and device-related infection caused by organisms that remain fully susceptible to first-line...

Giovanni Mori, S. Urru, Alessandro Castelli et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.